{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:11:58Z","timestamp":1789164718319,"version":"build-2803163510"},"reference-count":376,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109428","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:32:35Z","timestamp":1667781155000},"page":"109428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"PB","title":["Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options"],"prefix":"10.1016","volume":"113","author":[{"given":"Yasaman","family":"Nazerian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Yassaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Nazerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.intimp.2022.109428_b0005","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2022.109428_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.593223","article-title":"Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies","volume":"12","author":"Lopes-Pacheco","year":"2021","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: A narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and Multiorgan Response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"issue":"23","key":"10.1016\/j.intimp.2022.109428_b0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2022.109428_b0035","series-title":"the Cytokines of the Immune System","first-page":"1","article-title":"Chapter 1 - Introduction\u2014Common Features About Cytokines","author":"Dembic","year":"2015"},{"issue":"23","key":"10.1016\/j.intimp.2022.109428_b0040","doi-asserted-by":"crossref","first-page":"23427","DOI":"10.18632\/aging.202193","article-title":"Evolution of COVID-19 in patients with autoimmune rheumatic diseases","volume":"12","author":"Pang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"7798","key":"10.1016\/j.intimp.2022.109428_b0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis.: Official Publ. Eur. Soc. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0065","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00912-2020","article-title":"Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review","volume":"56","author":"Ingraham","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0070","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: A review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0075","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1038\/s41467-020-19706-9","article-title":"Immune suppression in the early stage of COVID-19 disease","volume":"11","author":"Tian","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0080","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s10753-021-01519-7","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System","volume":"44","author":"Anaeigoudari","year":"2021","journal-title":"Inflammation"},{"issue":"3365","key":"10.1016\/j.intimp.2022.109428_b0085","article-title":"Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases","volume":"11","author":"Carsetti","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3476(84)80549-1","article-title":"Impaired natural killer activity in lymphohistiocytosis syndrome","volume":"104","author":"Perez","year":"1984","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","article-title":"Inflammasome activation at the crux of severe COVID-19","volume":"21","author":"Vora","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0110","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0115","first-page":"1","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2022.109428_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2022.109428_b0125","first-page":"1","article-title":"SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1","author":"Sun","year":"2022","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0135","doi-asserted-by":"crossref","unstructured":"S.J. Theobald, et al., The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1-beta secretion in COVID-19 patient-derived macrophages, 2020.","DOI":"10.21203\/rs.3.rs-30407\/v1"},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0140","doi-asserted-by":"crossref","first-page":"e14150","DOI":"10.15252\/emmm.202114150","article-title":"Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19","volume":"13","author":"Theobald","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/v13122513","article-title":"Inflammasomes and SARS-CoV-2 Infection","volume":"13","author":"Kaivola","year":"2021","journal-title":"Viruses"},{"issue":"7914","key":"10.1016\/j.intimp.2022.109428_b0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0155","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.1600714","article-title":"AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality","volume":"198","author":"Zhang","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0160","doi-asserted-by":"crossref","first-page":"110859","DOI":"10.1016\/j.biopha.2020.110859","article-title":"Innate and adaptive immune responses against coronavirus","volume":"132","author":"Hosseini","year":"2020","journal-title":"Biomed. & Pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","article-title":"Th1\/Th2 Cells","volume":"5","author":"Romagnani","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0175","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"827","key":"10.1016\/j.intimp.2022.109428_b0190","article-title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"7821","key":"10.1016\/j.intimp.2022.109428_b0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"6504","key":"10.1016\/j.intimp.2022.109428_b0220","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.109428_b0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"10223","key":"10.1016\/j.intimp.2022.109428_b0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. The Lancet"},{"issue":"1057","key":"10.1016\/j.intimp.2022.109428_b0235","article-title":"The Role of Interleukin 6 During Viral Infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113528","article-title":"The Two-Faced Cytokine IL-6 in Host Defense and Diseases","volume":"19","author":"Narazaki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109428_b0245","doi-asserted-by":"crossref","unstructured":"G. Magro, SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the \u2018culprit lesion\u2019 of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine: X, 2020. 2(2): p. 100029.","DOI":"10.1016\/j.cytox.2020.100029"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in COVID-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0255","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerging Microbes Infect."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/tjb-2021-0020","article-title":"Could IL-6 predict the clinical severity of COVID-19?","volume":"46","author":"Aykal","year":"2021","journal-title":"Turkish J. Biochem."},{"key":"10.1016\/j.intimp.2022.109428_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0270","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3332\/ecancer.2020.1022","article-title":"Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41419-018-1266-6","article-title":"Differential roles of TNF\u03b1-TNFR1 and TNF\u03b1-TNFR2 in the differentiation and function of CD4+Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2022.109428_b0295","doi-asserted-by":"crossref","first-page":"165974","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2013an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0300","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1172\/JCI113431","article-title":"Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition","volume":"81","author":"Okusawa","year":"1988","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0305","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41598-018-20220-8","article-title":"The inflammatory effects of TNF-\u03b1 and complement component 3 on coagulation","volume":"8","author":"Page","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0315","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2022.109428_b0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","article-title":"The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19","volume":"54","author":"Goker Bagca","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0330","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting Interleukin-6 Signaling in Clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0335","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000508247","article-title":"JAK Inhibition as a New Treatment Strategy for Patients with COVID-19","volume":"181","author":"Seif","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0340","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.2.1.22","article-title":"Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies","volume":"2","author":"D'Acquisto","year":"2002","journal-title":"Mol. Interv."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","article-title":"The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients","volume":"29","author":"Hariharan","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0355","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","article-title":"Shaping the nuclear action of NF-\u03baB","volume":"5","author":"Chen","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12033","article-title":"NF-\u03baB: roles and regulation in different CD4(+) T-cell subsets","volume":"252","author":"Oh","year":"2013","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0365","doi-asserted-by":"crossref","first-page":"13464","DOI":"10.1038\/s41598-021-92941-2","article-title":"Activation of NF-\u03baB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2","volume":"11","author":"Su","year":"2021","journal-title":"Sci. Rep."},{"issue":"7344","key":"10.1016\/j.intimp.2022.109428_b0370","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.intimp.2022.109428_b0375","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","article-title":"Advances in anti-viral immune defence: revealing the importance of the IFN JAK\/STAT pathway","volume":"74","author":"Raftery","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"4\u20135","key":"10.1016\/j.intimp.2022.109428_b0380","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","article-title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes","volume":"22","author":"Moreno-Eutimio","year":"2020","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury","volume":"133","author":"Imai","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0390","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2022.109428_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106946","article-title":"Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage","volume":"142","author":"Costa","year":"2022","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0400","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","article-title":"Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors","volume":"18","author":"Onomoto","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0405","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v30.i6.10","article-title":"Function and regulation of retinoic acid-inducible gene-I","volume":"30","author":"Matsumiya","year":"2010","journal-title":"Critical Reviews\u2122 in Immunology"},{"key":"10.1016\/j.intimp.2022.109428_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01586","article-title":"Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5","volume":"10","author":"Brisse","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0415","first-page":"1","article-title":"Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins","author":"Kim","year":"2022","journal-title":"J. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00515-5","article-title":"Unique and complementary suppression of cGAS-STING and RNA sensing-triggered innate immune responses by SARS-CoV-2 proteins","volume":"6","author":"Rui","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.intimp.2022.109428_b0425","doi-asserted-by":"crossref","first-page":"e2343","DOI":"10.1002\/rmv.2343","article-title":"Crosstalk between RNA viruses and DNA sensors: Role of the cGAS-STING signalling pathway","author":"Fan","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00800-3","article-title":"Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduction Targeted Therapy"},{"issue":"23","key":"10.1016\/j.intimp.2022.109428_b0435","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.3390\/jcm10235660","article-title":"Efficacy, safety and future perspectives of JAK inhibitors in the IBD treatment","volume":"10","author":"Dudek","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-022-00967-3","article-title":"STING, a critical contributor to SARS-CoV-2 immunopathology","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"7899","key":"10.1016\/j.intimp.2022.109428_b0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS\u2013STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s42003-021-02983-5","article-title":"SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB","volume":"5","author":"Neufeldt","year":"2022","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0455","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/ijms20061445","article-title":"Differential Regulation of Type I and Type III Interferon Signaling","volume":"20","author":"Stanifer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0460","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0465","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0470","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","article-title":"Dysregulation of type I interferon responses in COVID-19","volume":"20","author":"Acharya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6504","key":"10.1016\/j.intimp.2022.109428_b0475","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0480","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0485","article-title":"Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome","volume":"11","author":"Satoh","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0490","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1574-695X.2006.00045.x","article-title":"Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis","volume":"46","author":"Lin","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.intimp.2022.109428_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2020.06.008","article-title":"Mitochondria and microbiota dysfunction in COVID-19 pathogenesis","volume":"54","author":"Saleh","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.intimp.2022.109428_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.578599","article-title":"Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2","volume":"11","author":"Gatti","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109428_b0505","article-title":"Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases","volume":"12","author":"Ganji","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2022.109428_b0510","article-title":"SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment","volume":"12","author":"Shang","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2022.109428_b0515","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2018.00832","article-title":"Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases","volume":"9","author":"Grazioli","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0520","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-6-19","article-title":"Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers","volume":"6","author":"Li","year":"2013","journal-title":"J. Hematology & Oncology"},{"issue":"10","key":"10.1016\/j.intimp.2022.109428_b0525","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0530","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"6\u20137","key":"10.1016\/j.intimp.2022.109428_b0535","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbabio.2010.01.032","article-title":"Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species","volume":"1797","author":"Daiber","year":"2010","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0540","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome","volume":"26","author":"Wang","year":"2008","journal-title":"The Am. J. Emergency Med."},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0545","first-page":"771","article-title":"Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults","volume":"97","author":"Aikawa","year":"1996","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0550","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the Eye of the Cytokine Storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"1446","key":"10.1016\/j.intimp.2022.109428_b0555","article-title":"The COVID-19 Cytokine Storm; What We Know So Far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0560","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0020-1383(97)00057-0","article-title":"Plasma cytokines and endotoxin levels in patients with severe injury and their relationship with organ damage","volume":"28","author":"Jiang","year":"1997","journal-title":"Injury"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0565","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MPA.0b013e3182240552","article-title":"Cytokines and Organ Failure in Acute Pancreatitis: Inflammatory Response in Acute Pancreatitis","volume":"41","author":"Malmstr\u00f8m","year":"2012","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0570","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1378\/chest.103.2.565","article-title":"Serum Cytokine Levels in Human Septic Shock: Relation to Multiple-System Organ Failure and Mortality","volume":"103","author":"Pinsky","year":"1993","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-7241-17-49","article-title":"IL-6 predicts organ dysfunction and mortality in patients with multiple injuries","volume":"17","author":"Frink","year":"2009","journal-title":"Scand. J. Trauma, Resuscitation and Emergency Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0580","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1097\/00003246-200205001-00021","article-title":"Markers of endothelial damage in organ dysfunction and sepsis","volume":"30","author":"Reinhart","year":"2002","journal-title":"Crit. Care Med."},{"issue":"6 Pt 1","key":"10.1016\/j.intimp.2022.109428_b0585","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1164\/ajrccm.153.6.8665045","article-title":"Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1","volume":"153","author":"Pugin","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"18","key":"10.1016\/j.intimp.2022.109428_b0590","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The Acute Respiratory Distress Syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0595","doi-asserted-by":"crossref","first-page":"L1037","DOI":"10.1152\/ajplung.2001.281.5.L1037","article-title":"Transcriptional mechanisms of acute lung injury","volume":"281","author":"Fan","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2022.109428_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: A review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0605","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/ATVBAHA.120.314515","article-title":"COVID-19 and respiratory system disorders: current knowledge, future clinical and translational research questions","volume":"40","author":"Brosnahan","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2022.109428_b0610","doi-asserted-by":"crossref","unstructured":"P.G. Gibson, L. Qin, S.H. Puah, COVID\u201019 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre\u2010COVID\u201019 ARDS, Med. J. Australia, 213(2) (2020) 54-56. e1.","DOI":"10.5694\/mja2.50674"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/187153006777442413","article-title":"The lung in sepsis: guilty or innocent?","volume":"6","author":"Costa","year":"2006","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0620","doi-asserted-by":"crossref","first-page":"C767","DOI":"10.1152\/ajpcell.1992.263.4.C767","article-title":"Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC","volume":"263","author":"Myers","year":"1992","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0625","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.146.2.592","article-title":"Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and-independent binding mechanisms","volume":"146","author":"Thornhill","year":"1991","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0630","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4049\/jimmunol.159.2.912","article-title":"Cytokine-induced neutrophil-mediated injury of human endothelial cells","volume":"159","author":"Bratt","year":"1997","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0635","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1084\/jem.186.11.1831","article-title":"Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation","volume":"186","author":"Haimovitz-Friedman","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.109428_b0640","doi-asserted-by":"crossref","unstructured":"C. Pelaia, et al., Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Therapeutic advances in respiratory disease, 2020. 14: p. 1753466620933508.","DOI":"10.1177\/1753466620933508"},{"key":"10.1016\/j.intimp.2022.109428_b0645","doi-asserted-by":"crossref","unstructured":"C. Wang, et al., Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19, 2020.","DOI":"10.21203\/rs.3.rs-19346\/v1"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0650","first-page":"485","article-title":"Causes of mortality in patients with the adult respiratory distress syndrome","volume":"132","author":"Montgomery","year":"1985","journal-title":"Am. Rev. Respiratory Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0655","doi-asserted-by":"crossref","first-page":"159","DOI":"10.31083\/j.rcm.2021.01.238","article-title":"Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis","volume":"22","author":"Zhao","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2022.109428_b0660","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2022.109428_b0665","first-page":"e13703","article-title":"Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19","author":"Melillo","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.intimp.2022.109428_b0670","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","article-title":"Targeting Interleukin-1 in Heart Disease","volume":"128","author":"Tassell","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0675","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/01.CIR.96.6.1937","article-title":"Chronic Hypoxia Modulates the Interleukin-1\u03b2\u2013Stimulated Inducible Nitric Oxide Synthase Pathway in Cardiac Myocytes","volume":"96","author":"Kacimi","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0680","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.12.015","article-title":"IL-1\u03b2 and TNF-\u03b1 upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart","volume":"38","author":"Gurantz","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0685","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of Inflammation in Heart Failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0690","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-5273(96)02805-7","article-title":"Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure","volume":"57","author":"Deng","year":"1996","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0695","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.healun.2003.07.023","article-title":"Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure","volume":"23","author":"Gwechenberger","year":"2004","journal-title":"J. Heart Lung Transplantation"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0700","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/00003246-200107001-00032","article-title":"Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome","volume":"29","author":"Marshall","year":"2001","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b0705","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1172\/JCI136908","article-title":"IL-1\u03b2 suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury","volume":"130","author":"Xiong","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0710","doi-asserted-by":"crossref","first-page":"144","DOI":"10.14336\/AD.2021.0704","article-title":"Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review","volume":"13","author":"Chen","year":"2022","journal-title":"Aging and Disease"},{"key":"10.1016\/j.intimp.2022.109428_b0715","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2021.02.010","article-title":"Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis","volume":"201","author":"Zhou","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2022.109428_b0720","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14878","article-title":"DIC in COVID-19: Implications for Prognosis and Treatment?","author":"Seitz","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0725","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.xkme.2020.11.008","article-title":"The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis","volume":"3","author":"Silver","year":"2021","journal-title":"Kidney Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0730","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2020050615","article-title":"AKI in hospitalized patients with COVID-19","volume":"32","author":"Chan","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b0735","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jclinpath-2020-207023","article-title":"High burden of acute kidney injury in COVID-19 pandemic: systematic review and meta-analysis","volume":"74","author":"Oliveira","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2022.109428_b0740","doi-asserted-by":"crossref","unstructured":"Z. Li, et al., Kidney Dysfunctions of COVID-19 Patients: A Multi-Centered, Retrospective, Observational Study, SSRN Electron. J., 2020.","DOI":"10.2139\/ssrn.3556634"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0745","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0750","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12985-021-01588-y","article-title":"Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction","volume":"18","author":"Wang","year":"2021","journal-title":"Virology J."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0755","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13613-020-00734-z","article-title":"Acute kidney injury in patients with SARS-CoV-2 infection","volume":"10","author":"Joseph","year":"2020","journal-title":"Ann. Intensive Care"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0760","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2020040426","article-title":"Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort","volume":"31","author":"Xia","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0765","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00467-020-04715-z","article-title":"Be aware of acute kidney injury in critically ill children with COVID-19","volume":"36","author":"Wang","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2022.109428_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155589","article-title":"Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients","volume":"146","author":"Gradin","year":"2021","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0775","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ekir.2021.01.011","article-title":"Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19","volume":"6","author":"Hardenberg","year":"2021","journal-title":"Kidney Int. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b0780","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081571","article-title":"SARS-CoV-2 Renal Impairment in Critical Care: An Observational Study of 42 Cases (Kidney COVID)","volume":"10","author":"Molina Barragan","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2022.109428_b0785","first-page":"7","article-title":"Identify the Risk Factors of COVID-19-Related Acute Kidney Injury: A Single-Center, Retrospective Cohort Study","author":"Wang","year":"2020","journal-title":"Front. Med."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0790","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0795","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1164\/rccm.201602-0420CP","article-title":"Lung-Kidney Cross-Talk in the Critically Ill Patient","volume":"194","author":"Husain-Syed","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b0800","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"issue":"1\u20134","key":"10.1016\/j.intimp.2022.109428_b0805","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000363203","article-title":"The central role of renal microcirculatory dysfunction in the pathogenesis of acute kidney injury","volume":"127","author":"Ince","year":"2014","journal-title":"Nephron Clin. Practice"},{"key":"10.1016\/j.intimp.2022.109428_b0810","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0815","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00134-020-06059-6","article-title":"Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation","volume":"46","author":"Leisman","year":"2020","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0820","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semnephrol.2018.10.007","article-title":"Kidney-Immune System Crosstalk in AKI","volume":"39","author":"Singbartl","year":"2019","journal-title":"Semin. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0825","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0830","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016345","article-title":"Inflammation and the blood microvascular system","volume":"7","author":"Pober","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0835","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b0845","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"issue":"16","key":"10.1016\/j.intimp.2022.109428_b0850","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/cid\/ciaa445","article-title":"Comment on the potential risks of sexual and vertical transmission of COVID-19","volume":"71","author":"Scorzolini","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.intimp.2022.109428_b0855","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/cid\/ciaa375","article-title":"SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection","volume":"71","author":"Qiu","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0860","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajog.2020.04.038","article-title":"Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract","volume":"223","author":"Cui","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0865","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/biolre\/ioaa050","article-title":"Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients","volume":"103","author":"Song","year":"2020","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0870","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.fertnstert.2020.04.024","article-title":"No evidence of severe acute respiratory syndrome\u2013coronavirus 2 in semen of males recovering from coronavirus disease 2019","volume":"113","author":"Pan","year":"2020","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0875","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41423-020-00604-5","article-title":"Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients","volume":"18","author":"Ma","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b0880","article-title":"Male reproductive system inflammation after healing from coronavirus disease 2019","author":"Morselli","year":"2021","journal-title":"Andrology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0885","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/andr.13019","article-title":"Short-term effects of COVID-19 on semen parameters: a multicenter study of 69 cases","volume":"9","author":"Erbay","year":"2021","journal-title":"Andrology"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0890","doi-asserted-by":"crossref","first-page":"e14157","DOI":"10.1111\/and.14157","article-title":"Impaired semen parameters in patients with confirmed SARS-CoV-2 infection: A prospective cohort study","volume":"53","author":"Pazir","year":"2021","journal-title":"Andrologia"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0895","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/2090598X.2019.1599624","article-title":"Oxidative stress and sperm function: A systematic review on evaluation and management","volume":"17","author":"Dutta","year":"2019","journal-title":"Arab J. Urology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100559","article-title":"Understanding the cross-talk between mediators of infertility and COVID-19","volume":"21","author":"Rajak","year":"2021","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.intimp.2022.109428_b0905","doi-asserted-by":"crossref","unstructured":"M. Lamamri, et al., Priapism in a patient with coronavirus disease 2019 (COVID-19), Am. J. Emergency Med., 2021. 39: p. 251. e5-251. e7.","DOI":"10.1016\/j.ajem.2020.06.027"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0910","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5534\/wjmh.210055","article-title":"COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis","volume":"39","author":"Kresch","year":"2021","journal-title":"The World J. Men's Health"},{"key":"10.1016\/j.intimp.2022.109428_b0915","first-page":"2022","article-title":"Ischemic Priapism Progressing to Penile Gangrene in a Patient with COVID-19 Infection: A Case Report with Literature Review","author":"Alsaedi","year":"2022","journal-title":"Case Rep. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.esxm.2020.100293","article-title":"An online questionnaire survey on the sexual life and sexual function of chinese adult men during the coronavirus disease 2019 epidemic","volume":"9","author":"Fang","year":"2021","journal-title":"Sexual Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0925","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/andr.13003","article-title":"\u201cMask up to keep it up\u201d: Preliminary evidence of the association between erectile dysfunction and COVID-19","volume":"9","author":"Sansone","year":"2021","journal-title":"Andrology"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0930","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/REP-20-0523","article-title":"Evaluating the impact of COVID-19 on male reproduction","volume":"161","author":"Tian","year":"2021","journal-title":"Reproduction"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0935","doi-asserted-by":"crossref","first-page":"e236786","DOI":"10.1136\/bcr-2020-236786","article-title":"Left gonadal vein thrombosis in a patient with COVID-19-associated coagulopathy","volume":"13","author":"Veyseh","year":"2020","journal-title":"BMJ Case Reports CP"},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b0940","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.radcr.2021.08.024","article-title":"Ovarian vein thrombosis as a first manifestation of COVID-19 infection","volume":"16","author":"Badrawi","year":"2021","journal-title":"Radiol. Case Rep."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b0945","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14740\/jmc3791","article-title":"Premature Ovarian Failure Related to SARS-CoV-2 Infection","volume":"13","author":"Puca","year":"2022","journal-title":"J. Med. Cases"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0950","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11239-021-02433-3","article-title":"Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports","volume":"52","author":"Fatimazahra","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b0955","doi-asserted-by":"crossref","first-page":"p. rjab389","DOI":"10.1093\/jscr\/rjab389","article-title":"Diagnostic laparoscopy and oophorectomy for ovarian vein thrombosis in a patient with COVID-19: a surgical case report and literature review","volume":"2021","author":"Glanzer","year":"2021","journal-title":"J. Surgical Case Rep."},{"key":"10.1016\/j.intimp.2022.109428_b0960","first-page":"1286","article-title":"Premature ovarian failure -A long COVID sequelae","volume":"25","author":"Madaan","year":"2021","journal-title":"Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b0965","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11239-020-02177-6","article-title":"Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report","volume":"50","author":"Mohammadi","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b0970","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b0975","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jclinpath-2020-206995","article-title":"Histopathological observations in COVID-19: a systematic review","volume":"74","author":"Deshmukh","year":"2021","journal-title":"J. Clin. Pathol."},{"issue":"6499","key":"10.1016\/j.intimp.2022.109428_b0980","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2022.109428_b0985","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/microorganisms8101514","article-title":"Gut microbiota dysbiosis\u2013immune hyperresponse\u2013inflammation triad in coronavirus disease 2019 (COVID-19): impact of pharmacological and nutraceutical approaches","volume":"8","author":"Ferreira","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2022.109428_b0990","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607734","article-title":"Could perturbation of gut microbiota possibly exacerbate the severity of COVID-19 via cytokine storm?","volume":"11","author":"Vignesh","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b0995","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1040841X.2016.1176988","article-title":"Gut\u2013lung axis: the microbial contributions and clinical implications","volume":"43","author":"He","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1000","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ibd\/izx029","article-title":"A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease","volume":"24","author":"Gon\u00e7alves","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1005","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","article-title":"Alterations in gut microbiota of patients with COVID-19 during time of hospitalization","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2022.109428_b1010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clinimag.2020.11.054","article-title":"Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation","volume":"73","author":"Keshavarz","year":"2021","journal-title":"Clin. Imaging"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1015","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1053\/j.gastro.2020.06.041","article-title":"Poor outcome of intestinal ischemic manifestations of COVID-19","volume":"159","author":"Norsa","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b1020","first-page":"1069","article-title":"Vascular thrombosis and vasculitis in the gastrointestinal tract are associated with poor prognosis in patients with COVID-19","volume":"14","author":"Cui","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jgh.15047","article-title":"Covid-19 and the digestive system","volume":"35","author":"Wong","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/PAS.0000000000001755","article-title":"Intestinal abnormalities in patients with SARS-CoV-2 infection: histopathologic changes reflect mechanisms of disease","volume":"46","author":"Yantiss","year":"2022","journal-title":"Am. J. Surgical Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000513375","article-title":"Clinical and intestinal histopathological findings in SARS-CoV-2\/COVID-19 patients with hematochezia","volume":"15","author":"Cho","year":"2021","journal-title":"Case Rep. Gastroenterology"},{"key":"10.1016\/j.intimp.2022.109428_b1040","first-page":"1409","article-title":"Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1045","doi-asserted-by":"crossref","first-page":"e13859","DOI":"10.1111\/dth.13859","article-title":"Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems","volume":"33","author":"Garg","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4240\/wjgs.v13.i6.574","article-title":"Acute pancreatitis and COVID-19: A literature review","volume":"13","author":"de S\u00e1","year":"2021","journal-title":"World J. Gastrointestinal Surgery"},{"issue":"15","key":"10.1016\/j.intimp.2022.109428_b1055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155475","article-title":"SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms","volume":"21","author":"Pennisi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.23736\/S0375-9393.20.14772-2","article-title":"First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem","volume":"86","author":"Bulfamante","year":"2020","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.intimp.2022.109428_b1065","article-title":"Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System","volume":"11","author":"Reza-Zald\u00edvar","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jmv.25915","article-title":"Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"92","author":"Paniz-Mondolfi","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11481-020-09975-y","article-title":"SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation","volume":"16","author":"Reynolds","year":"2021","journal-title":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood\u2013brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.intimp.2022.109428_b1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1090","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11481-021-10029-0","article-title":"SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation","volume":"16","author":"DeOre","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.intimp.2022.109428_b1095","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2022.109428_b1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.02.002","article-title":"SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders","volume":"58","author":"Amruta","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b1105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/AJP.0b013e3181e8d9b6","article-title":"Interleukin-6 levels in tension headache patients","volume":"26","author":"Ko\u00e7er","year":"2010","journal-title":"The Clinical journal of pain"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b1110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0333102414559734","article-title":"Increased serum levels of interleukin-8 in patients with tension-type headache","volume":"35","author":"Domingues","year":"2015","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","article-title":"Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache","volume":"29","author":"B\u00f8","year":"2009","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/fampra\/cmab076","article-title":"Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review","volume":"39","author":"van Kessel","year":"2022","journal-title":"Fam. Pract."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/vaccines9050497","article-title":"Post-COVID syndrome: an insight on its pathogenesis","volume":"9","author":"Maltezou","year":"2021","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/NNR.0000000000000565","article-title":"Post-COVID-19 Syndrome","volume":"71","author":"Pierce","year":"2022","journal-title":"Nurs. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1135","article-title":"Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum","volume":"8","author":"Ong","year":"2021","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.intimp.2022.109428_b1140","series-title":"Inflammation during early post-acute COVID-19 is associated with reduced exercise capacity and Long COVID symptoms after 1 year","author":"Durstenfeld","year":"2022"},{"key":"10.1016\/j.intimp.2022.109428_b1145","doi-asserted-by":"crossref","first-page":"e00749","DOI":"10.1016\/j.btre.2022.e00749","article-title":"Can natural products modulate cytokine storm in SARS-CoV2 patients?","author":"Abou Baker","year":"2022","journal-title":"Biotechnol. Rep,"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1150","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1160","doi-asserted-by":"crossref","first-page":"e048391","DOI":"10.1136\/bmjopen-2020-048391","article-title":"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study","volume":"11","author":"Dennis","year":"2021","journal-title":"BMJ open"},{"key":"10.1016\/j.intimp.2022.109428_b1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2020.100173","article-title":"Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines-two case reports","volume":"9","author":"Alpert","year":"2020","journal-title":"Brain, Behavior, & Immunity-Health"},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b1170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/qjmed\/hcaa255","article-title":"Post-COVID-19 pneumonia pulmonary fibrosis","volume":"113","author":"Tale","year":"2020","journal-title":"QJM: An Int. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/cells10020386","article-title":"Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2022.109428_b1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117271","article-title":"Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom","volume":"420","author":"Ortelli","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2022.109428_b1185","doi-asserted-by":"crossref","first-page":"2246.e3","DOI":"10.1016\/j.ajem.2020.05.058","article-title":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department","volume":"38","author":"Waltuch","year":"2020","journal-title":"Am. J. Emergency Med."},{"key":"10.1016\/j.intimp.2022.109428_b1190","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.626182","article-title":"Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment","volume":"8","author":"McMurray","year":"2020","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1195","doi-asserted-by":"crossref","first-page":"e241059","DOI":"10.1136\/bcr-2020-241059","article-title":"Post COVID-19 sequelae: venous thromboembolism complicated by lower GI bleed","volume":"14","author":"Kumar","year":"2021","journal-title":"BMJ Case Reports"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1200","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s13760-022-01923-2","article-title":"Post-acute COVID-19 syndrome presented as a cerebral and systemic vasculitis: a case report","volume":"122","author":"Ivanovic","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b1205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12968-021-00841-1","article-title":"Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry","volume":"23","author":"Aeschlimann","year":"2021","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1215","article-title":"Inflammatory and Cardiac Biomarkers in Relation with Post-Acute COVID-19 and Mortality: What We Know after Successive Pandemic Waves","volume":"12","author":"Lionte","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11883-022-01032-8","article-title":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician","volume":"24","author":"Tobler","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b1225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.intimp.2022.109428_b1230","article-title":"NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b1235","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27684","article-title":"Gut dysbiosis and long COVID-19: Feeling gutted","author":"Giannos","year":"2022","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/eji.201646721","article-title":"Contributions of the intestinal microbiome in lung immunity","volume":"48","author":"McAleer","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1250","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.psj.2019.12.011","article-title":"Microbiome and pathogen interaction with the immune system","volume":"99","author":"Kogut","year":"2020","journal-title":"Poult. Sci."},{"issue":"7902","key":"10.1016\/j.intimp.2022.109428_b1255","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jiph.2022.01.007","article-title":"Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity","volume":"15","author":"Alefishat","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.intimp.2022.109428_b1265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.856072","article-title":"SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment\/Respiratory Coinfection","volume":"13","author":"Elkoshi","year":"2022","journal-title":"Front. Immunol."},{"issue":"7902","key":"10.1016\/j.intimp.2022.109428_b1270","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"issue":"7902","key":"10.1016\/j.intimp.2022.109428_b1275","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"issue":"7918","key":"10.1016\/j.intimp.2022.109428_b1280","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-022-04865-0","article-title":"Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination","volume":"607","author":"Suryawanshi","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b1285","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1290","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1295","first-page":"529","article-title":"Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19","volume":"38","author":"Sciascia","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109428_b1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","author":"Toniati","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2022.109428_b1305","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.586221","article-title":"Addition of Tocilizumab to the standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis","volume":"7","author":"Boregowda","year":"2020","journal-title":"Frontiers in medicine"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbmt.2018.09.024","article-title":"American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group survey on chimeric antigen receptor T cell therapy administrative, logistic, and toxicity management practices in the United States","volume":"25","author":"Mahmoudjafari","year":"2019","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.intimp.2022.109428_b1315","article-title":"IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study","author":"Gritti","year":"2020","journal-title":"Medrxiv"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1320","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1325","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of theCytokine Storm'in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1330","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jinf.2020.03.062","article-title":"The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis","volume":"81","author":"Yang","year":"2020","journal-title":"J. Infect."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b1335","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1340","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.129.6.1441","article-title":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-0127-9","article-title":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal transduction and targeted therapy"},{"issue":"10223","key":"10.1016\/j.intimp.2022.109428_b1350","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"The Lancet"},{"issue":"5411","key":"10.1016\/j.intimp.2022.109428_b1355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1360","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/jcm8071025","article-title":"The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity","volume":"8","author":"Zhou","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b1365","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","article-title":"Immune modulation by mesenchymal stem cells","volume":"312","author":"Rasmusson","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1370","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3727\/096368909X479677","article-title":"Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart","volume":"19","author":"Assis","year":"2010","journal-title":"Cell Transplant."},{"issue":"29","key":"10.1016\/j.intimp.2022.109428_b1375","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0704581104","article-title":"Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts","volume":"104","author":"Hashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1380","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stemcr.2020.09.003","article-title":"Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells","volume":"16","author":"Sch\u00e4fer","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1385","first-page":"36","article-title":"Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study","volume":"10","author":"Montanucci","year":"2021","journal-title":"American Journal of Stem Cells"},{"key":"10.1016\/j.intimp.2022.109428_b1390","doi-asserted-by":"crossref","unstructured":"Lanzoni, G., et al., Umbilical cord mesenchymal stem cells for COVID-19 ARDS: a double blind, phase 1\/2a, randomized controlled trial. 2020.","DOI":"10.2139\/ssrn.3696875"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.intimp.2022.109428_b1400","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109865","article-title":"Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes","volume":"144","author":"Taghavi-Farahabadi","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00063030-200519030-00005","article-title":"Anakinra","volume":"19","author":"Waugh","year":"2005","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1410","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1415","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/acr2.11135","article-title":"Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome","volume":"2","author":"Monteagudo","year":"2020","journal-title":"ACR open rheumatology"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1420","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: Re-analysis of a prior Phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1425","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.intimp.2022.109428_b1430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102537","article-title":"High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients","volume":"115","author":"Iglesias-Juli\u00e1n","year":"2020","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1435","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b1440","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S2213-2600(21)00377-5","article-title":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial","volume":"9","author":"Declercq","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.intimp.2022.109428_b1445","doi-asserted-by":"crossref","unstructured":"Mastroianni, A., et al., Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis. International Journal of Immunopathology and Pharmacology, 2021. 35: p. 20587384211059675.","DOI":"10.1177\/20587384211059675"},{"key":"10.1016\/j.intimp.2022.109428_b1450","doi-asserted-by":"crossref","unstructured":"Ucciferri, C., et al., Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol, 2020. 2(8): p. e457-ee458.","DOI":"10.1016\/S2665-9913(20)30167-3"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1455","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jama.2021.9508","article-title":"Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial","volume":"326","author":"Caricchio","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03020-3","article-title":"Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients","volume":"24","author":"Convertino","year":"2020","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-020-00931-6","article-title":"Jak inhibitors: What is new?","volume":"22","author":"Reddy","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1470","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41375-020-01087-z","article-title":"Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia","volume":"35","author":"D\u2019Alessio","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2022.109428_b1475","first-page":"1","article-title":"JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2022.109428_b1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2021.100755","article-title":"The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis","author":"Wijaya","year":"2021","journal-title":"Clinical epidemiology and global health"},{"issue":"11","key":"10.1016\/j.intimp.2022.109428_b1485","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1007\/s10067-021-05884-4","article-title":"Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials","volume":"40","author":"Patoulias","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1490","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1495","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00210-020-02035-5","article-title":"NF-\u03baB signalling as a pharmacological target in COVID-19: potential roles for IKK\u03b2 inhibitors","volume":"394","author":"Kandasamy","year":"2021","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"5234","key":"10.1016\/j.intimp.2022.109428_b1500","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.270.5234.283","article-title":"Role of transcriptional activation of I\u03baB\u03b1 in mediation of immunosuppression by glucocorticoids","volume":"270","author":"Scheinman","year":"1995","journal-title":"Science"},{"issue":"5234","key":"10.1016\/j.intimp.2022.109428_b1505","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-\u03baB activity through induction of I\u03baB synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.2.1.22","article-title":"Inhibition of nuclear factor kappa B (NF-B)","volume":"2","author":"D'Acquisto","year":"2002","journal-title":"Mol. Interventions"},{"issue":"6706","key":"10.1016\/j.intimp.2022.109428_b1515","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I\u03baB kinase-\u03b2","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"issue":"5174","key":"10.1016\/j.intimp.2022.109428_b1520","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1525","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0701652","article-title":"Modulation of transcription factor NF-\u03baB by enantiomers of the nonsteroidal drug ibuprofen","volume":"123","author":"Scheuren","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"38","key":"10.1016\/j.intimp.2022.109428_b1530","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.274.38.27307","article-title":"Sulindac inhibits activation of the NF-\u03baB pathway","volume":"274","author":"Yamamoto","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b1535","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0006-2952(00)00371-3","article-title":"Oxidative stress interference with the nuclear factor-\u03baB activation pathways","volume":"60","author":"Schoonbroodt","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1540","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","article-title":"Redox regulation of NF-kappa B activation","volume":"22","author":"Floh\u00e9","year":"1997","journal-title":"Free Radical Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1545","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.157.4.1630","article-title":"In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation","volume":"157","author":"Blackwell","year":"1996","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b1550","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/01.CIR.100.12.1330","article-title":"Inhibition of NF-\u03baB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes","volume":"100","author":"Liu","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1555","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0026-895X(24)23027-3","article-title":"Pyrrolidine dithiocarbamate prevents I-\u03baB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs","volume":"55","author":"Liu","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1560","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.133.5.1083","article-title":"Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression","volume":"133","author":"Kretz-Remy","year":"1996","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1565","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/bbrc.1993.1620","article-title":"Inhibition of NF-\u03baB activation by vitamin E derivatives","volume":"193","author":"Suzuki","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1570","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/13880209.2022.2055090","article-title":"Systematic identification of the interventional mechanism of Qingfei Xiaoyan Wan (QFXYW) in treatment of the cytokine storm in acute lung injury using transcriptomics-based system pharmacological analyses","volume":"60","author":"Hou","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.intimp.2022.109428_b1575","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"05","key":"10.1016\/j.intimp.2022.109428_b1580","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1142\/S0192415X21500518","article-title":"Traditional Chinese medicine decoctions significantly reduce the mortality in severe and critically ill patients with COVID-19: a retrospective cohort study","volume":"49","author":"Sun","year":"2021","journal-title":"The American journal of Chinese medicine"},{"key":"10.1016\/j.intimp.2022.109428_b1585","doi-asserted-by":"crossref","unstructured":"Mardaneh, J., et al., Inhibiting NF-\u03baB During Cytokine Storm in COVID-19: Potential Role of Natural Products as a Promising Therapeutic Approach. 2021.","DOI":"10.20944\/preprints202106.0130.v1"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1590","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0253-7613.16209","article-title":"Curcumin: a natural antiinflammatory agent","volume":"37","author":"Kohli","year":"2005","journal-title":"Indian Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1595","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5142\/jgr.2012.36.4.354","article-title":"Ginseng, the'immunity boost': the effects of Panax ginseng on immune system","volume":"36","author":"Kang","year":"2012","journal-title":"J. Ginseng Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1600","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/eji.200535138","article-title":"The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals","volume":"36","author":"Ahn","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1605","doi-asserted-by":"crossref","DOI":"10.5530\/pres.14.3.33","article-title":"Ayurveda: The Prominence of Herbal Medicine in Containment of COVID-19","volume":"14","author":"Meenakshi","year":"2022","journal-title":"Pharmacognosy Research"},{"key":"10.1016\/j.intimp.2022.109428_b1610","doi-asserted-by":"crossref","unstructured":"Dash, M., N. Joshi, and Y. Tripathi, Identification of therapeutic targets for controlling COVID-19 pandemic by traditional system of Ayurvedic medicines: A systematic review. 2020.","DOI":"10.56042\/ijtk.v19i0.37463"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1615","doi-asserted-by":"crossref","first-page":"417","DOI":"10.14719\/pst.2020.7.3.831","article-title":"A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment of Covid-19","volume":"7","author":"Niraj","year":"2020","journal-title":"Plant Science Today"},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1620","first-page":"336","article-title":"Negative Interference of Ashwagandha, an Indian Ayurveda Medicine Indicated for Preventing COVID-19, in IL-6 Immunoassay","volume":"52","author":"Dasgupta","year":"2022","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"S2","key":"10.1016\/j.intimp.2022.109428_b1625","doi-asserted-by":"crossref","first-page":"594","DOI":"10.53730\/ijhs.v6nS2.5040","article-title":"Approach of Ayurveda in post COVID management","volume":"6","author":"Wajpeyi","year":"2022","journal-title":"International journal of health sciences"},{"key":"10.1016\/j.intimp.2022.109428_b1630","doi-asserted-by":"crossref","unstructured":"Bapat, V., et al., Perspectives on \u2018Kamsaharitaki\u2019: an Ayurvedic Formulation for COVID-19 related Multisystem Inflammatory Syndrome (MIS). 2022.","DOI":"10.37591\/joayush.v11i1.2575"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1635","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10787-021-00911-x","article-title":"Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm","volume":"30","author":"Ratheesh","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.intimp.2022.109428_b1640","first-page":"1","article-title":"Probiotics as a Potential Immuno Modulator to Combat Coronavirus Disease (covid-19) Infection","volume":"13","author":"Ghattargi","year":"2022","journal-title":"Archives of Clinical Microbiology"},{"issue":"12","key":"10.1016\/j.intimp.2022.109428_b1645","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.643","article-title":"The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy","volume":"11","author":"Wu","year":"2021","journal-title":"Clinical and translational medicine"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1650","first-page":"1","article-title":"Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID19: A singlearm, doubleblind, prospective trial combined with an in vitro cytokine response assay","volume":"23","author":"Kageyama","year":"2022","journal-title":"Exp. Therapeutic Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1655","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post\u2013COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"Myall","year":"2021","journal-title":"Ann. Am. Thoracic Soc."},{"issue":"8","key":"10.1016\/j.intimp.2022.109428_b1660","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"The Lancet Respiratory Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1665","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2022.109428_b1670","unstructured":"Bai, C., et al., Updated guidance on the management of COVID-19: from an American Thoracic Society\/European Respiratory Society coordinated international task force (29 July 2020). European Respiratory Review, 2020. 29(157)."},{"issue":"23","key":"10.1016\/j.intimp.2022.109428_b1675","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2022.109428_b1680","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100086","article-title":"Therapeutics for COVID-19 and post COVID-19 complications: An update","volume":"3","author":"Basu","year":"2022","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"16","key":"10.1016\/j.intimp.2022.109428_b1685","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1690","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00296-019-04456-9","article-title":"Tocilizumab-induced anaphylaxis in patients with adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis: a case-based review","volume":"40","author":"Park","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1695","first-page":"541","article-title":"Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials","volume":"56","author":"Moots","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1700","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2022.109428_b1705","unstructured":"Roche, H.-L., A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia. 2020."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0835-7","article-title":"Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a retrospective cohort study","volume":"17","author":"Curtis","year":"2015","journal-title":"Arthritis Research & Therapy"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b1715","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.40176","article-title":"Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis","volume":"69","author":"Genovese","year":"2017","journal-title":"Arthritis & Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1720","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbspin.2016.04.013","article-title":"Immunogenicity of tocilizumab in patients with rheumatoid arthritis","volume":"84","author":"Sigaux","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.intimp.2022.109428_b1725","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S2352-3026(19)30257-1","article-title":"Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials","volume":"7","author":"van Rhee","year":"2020","journal-title":"The Lancet Haematology"},{"key":"10.1016\/j.intimp.2022.109428_b1730","doi-asserted-by":"crossref","first-page":"973246","DOI":"10.3389\/fphar.2022.973246","article-title":"Immune-related adverse events of biological immunotherapies used in COVID-19","volume":"13","author":"Baracaldo-Santamar\u00eda","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109428_b1735","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/PROM.S140011","article-title":"Impact of siltuximab on patient-related outcomes in multicentric Castleman\u2019s disease","volume":"9","author":"Sitenga","year":"2018","journal-title":"Patient Related Outcome Measures"},{"key":"10.1016\/j.intimp.2022.109428_b1740","first-page":"15","article-title":"Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes","volume":"6","author":"Bachove","year":"2014","journal-title":"Open Access Rheumatology: Research and Reviews"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1745","first-page":"1","article-title":"A review on the toxic effects of medicines used in corona virus disease 2019 (Covid-19) treatment","volume":"2","author":"Aysegul","year":"2022","journal-title":"DAHUDER Medical Journal"},{"issue":"10","key":"10.1016\/j.intimp.2022.109428_b1750","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s42399-020-00485-9","article-title":"A review on current repurposing drugs for the treatment of COVID-19: reality and challenges","volume":"2","author":"Hossen","year":"2020","journal-title":"SN comprehensive clinical medicine"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1755","first-page":"102","article-title":"Mechanism and adverse effects of COVID-19 drugs: a basic review","volume":"13","author":"Zadeh","year":"2021","journal-title":"International Journal of Physiology, Pathophysiology and Pharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-022-02172-w","article-title":"Effects of tocilizumab and dexamethasone on the downregulation of proinflammatory cytokines and upregulation of antioxidants in the lungs in oleic acid-induced ARDS","volume":"23","author":"Terzi","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2022.109428_b1765","article-title":"Characterization, potential application and limitation of medicinal herbs in COVID-19","author":"Sivakumar","year":"2022","journal-title":"A review."},{"key":"10.1016\/j.intimp.2022.109428_b1770","doi-asserted-by":"crossref","unstructured":"Bentley, E., et al., SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19. 2021.","DOI":"10.1101\/2021.12.26.474085"},{"key":"10.1016\/j.intimp.2022.109428_b1775","article-title":"The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters","author":"Diamond","year":"2021","journal-title":"Res Sq"},{"issue":"17","key":"10.1016\/j.intimp.2022.109428_b1780","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3390\/jcm10173782","article-title":"Long COVID: Distinction between organ damage and deconditioning","volume":"10","author":"Kersten","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2022.109428_b1785","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117179","article-title":"Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community","volume":"419","author":"Wijeratne","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2022.109428_b1790","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2022.101012","article-title":"Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS)","volume":"40","author":"Elseidy","year":"2022","journal-title":"IJC Heart & Vasculature"},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b1795","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/gerona\/glaa146","article-title":"Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy","volume":"75","author":"Palmieri","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1800","first-page":"5350","article-title":"Identification of risk factors for sepsis-associated mortality by gene expression profiling analysis","volume":"17","author":"Qi","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2022.109428_b1805","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3389\/fimmu.2020.02147","article-title":"What\u2019s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses","author":"Gadi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b1810","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.maturitas.2020.06.017","article-title":"Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis","volume":"141","author":"P\u00e9rez-L\u00f3pez","year":"2020","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1815","doi-asserted-by":"crossref","first-page":"e0245556","DOI":"10.1371\/journal.pone.0245556","article-title":"Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area","volume":"16","author":"Vahidy","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109428_b1820","article-title":"Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers","volume":"8","author":"Jin","year":"2020","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1825","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2022.109428_b1830","first-page":"339","article-title":"Coronavirus COV-19\/SARS-CoV-2 affects women less than men: clinical response to viral infection","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1835","doi-asserted-by":"crossref","first-page":"e0250774","DOI":"10.1371\/journal.pone.0250774","article-title":"Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: insights from the MGH COVID-19 patient registry","volume":"16","author":"Lau","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109428_b1840","doi-asserted-by":"crossref","unstructured":"E.P. Scully, et al., Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19. in Open forum infectious diseases. 2021. Oxford University Press US.","DOI":"10.1093\/ofid\/ofab448"},{"key":"10.1016\/j.intimp.2022.109428_b1845","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105254","article-title":"Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage","volume":"99","author":"Kirtipal","year":"2022","journal-title":"Infection, Genetics and Evolution"},{"issue":"7","key":"10.1016\/j.intimp.2022.109428_b1850","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.intimp.2022.109428_b1855","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2007.06.013","article-title":"Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells","volume":"85","author":"Yang","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.intimp.2022.109428_b1860","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109428_b1865","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-021-00819-6","article-title":"Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks","volume":"6","author":"Ruhl","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10.1016\/j.intimp.2022.109428_b1870","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2020.10.005","article-title":"Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques","volume":"183","author":"Aid","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2022.109428_b1875","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 Cytokine Storm; What We Know So Far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109428_b1880","article-title":"Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922009134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922009134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:47:28Z","timestamp":1761587248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922009134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":376,"alternative-id":["S1567576922009134"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109428","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109428"}}